JP2022504792A - 炎症性疾患及び関連する感染の治療方法 - Google Patents

炎症性疾患及び関連する感染の治療方法 Download PDF

Info

Publication number
JP2022504792A
JP2022504792A JP2021520168A JP2021520168A JP2022504792A JP 2022504792 A JP2022504792 A JP 2022504792A JP 2021520168 A JP2021520168 A JP 2021520168A JP 2021520168 A JP2021520168 A JP 2021520168A JP 2022504792 A JP2022504792 A JP 2022504792A
Authority
JP
Japan
Prior art keywords
lactobacillus
disease
inflammation
gastrointestinal
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021520168A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020073088A5 (https=
JP2022504792A5 (https=
Inventor
フィンレイソン、ウェイン
Original Assignee
セルバトゥス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018903822A external-priority patent/AU2018903822A0/en
Application filed by セルバトゥス リミテッド filed Critical セルバトゥス リミテッド
Publication of JP2022504792A publication Critical patent/JP2022504792A/ja
Publication of JPWO2020073088A5 publication Critical patent/JPWO2020073088A5/ja
Publication of JP2022504792A5 publication Critical patent/JP2022504792A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2021520168A 2018-10-10 2019-10-10 炎症性疾患及び関連する感染の治療方法 Pending JP2022504792A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
AU2018903822A AU2018903822A0 (en) 2018-10-10 Compositions and methods of treatment of inflammatory conditions and infections
AU2018903822 2018-10-10
AU2018903823A AU2018903823A0 (en) 2018-10-10 Compositions and methods of treatment of conditions of the gastrointestinal tract
AU2018903823 2018-10-10
AU2019901175A AU2019901175A0 (en) 2019-04-05 Compositions and methods of treatment of conditions of the gastrointestinal tract
AU2019901175 2019-04-05
AU2019901176A AU2019901176A0 (en) 2019-04-05 Compositions and methods of treatment of inflammatory conditions and associated infections
AU2019901176 2019-04-05
PCT/AU2019/051092 WO2020073088A1 (en) 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections

Publications (3)

Publication Number Publication Date
JP2022504792A true JP2022504792A (ja) 2022-01-13
JPWO2020073088A5 JPWO2020073088A5 (https=) 2022-10-19
JP2022504792A5 JP2022504792A5 (https=) 2022-10-19

Family

ID=70163621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021520168A Pending JP2022504792A (ja) 2018-10-10 2019-10-10 炎症性疾患及び関連する感染の治療方法

Country Status (8)

Country Link
US (1) US20210338749A1 (https=)
EP (1) EP3863656A4 (https=)
JP (1) JP2022504792A (https=)
CN (1) CN114206362A (https=)
AU (1) AU2019356524A1 (https=)
CA (1) CA3124725A1 (https=)
SG (1) SG11202103567RA (https=)
WO (1) WO2020073088A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4255456A4 (en) * 2020-12-01 2024-09-25 Servatus Ltd METHODS TO IMPROVE SLEEP QUALITY
EP4259150A4 (en) * 2020-12-09 2024-12-25 Servatus Ltd COMBINATION THERAPY FOR INFLAMMATORY JOINT DISEASES
EP4387640A1 (en) * 2021-08-19 2024-06-26 Société des Produits Nestlé S.A. Postbiotic
EP4387639A1 (en) * 2021-08-19 2024-06-26 Société des Produits Nestlé S.A. Postbiotic
US12185767B2 (en) * 2021-11-05 2025-01-07 Trillium Medical Products, LLC Infused undergarment
AU2022400465A1 (en) * 2021-12-02 2024-07-18 Servatus Ltd Methods for the treatment of constipation
CN115725469B (zh) * 2022-11-28 2024-05-14 广西大学 一株副干酪乳杆菌及其应用
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用
CN117448227B (zh) * 2023-10-31 2024-09-20 西南大学 一株副干酪乳酪杆菌及其在预防和治疗痤疮中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010099024A (ja) * 2008-10-24 2010-05-06 Technical Research & Development Institute Ministry Of Defence 抗炎症効果を有する新規植物性乳酸菌株、該菌株を用いた炎症性腸疾患又は慢性下痢症に対する予防及び治療剤、抑制剤並びに添加剤
JP2016522810A (ja) * 2013-04-23 2016-08-04 テラジェン ホールディングス リミテッドＴｅｒｒａｇｅｎ Ｈｏｌｄｉｎｇｓ Ｌｉｍｉｔｅｄ 抗菌活性を有する細菌株およびそれを含む生物的防除組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
ITMI20032391A1 (it) * 2003-12-05 2005-06-06 Consiglio Nazionale Ricerche Olive da mensa contenenti microrganismi probiotici.
CN102014888A (zh) * 2007-07-03 2011-04-13 达努塔·克鲁谢夫斯卡 α-酮戊二酸的新医药用途
WO2011082218A1 (en) * 2009-12-31 2011-07-07 Ira Milton Trachtman Compositions and method for treatment and prophylaxis of inflammatory bowel disease
US9492487B2 (en) * 2010-02-01 2016-11-15 Matthew Ryan Garner Microbial product containing multiple microorganisms
ES2660775T3 (es) * 2011-05-16 2018-03-26 Belano Medical Ag Nuevas bacterias del ácido láctico y composiciones que las contienen contra los resfriados bacterianos
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR20150023132A (ko) * 2013-08-23 2015-03-05 (주) 아이투비 아토피 피부용 조성물
CN104000184A (zh) * 2013-12-09 2014-08-27 胡安然 一种调理萎缩性胃炎的膳食
WO2016179639A1 (en) * 2015-05-13 2016-11-17 Markson Ro Probiotic compositions and uses thereof
CN106860441B (zh) * 2017-02-10 2019-12-31 中国医学科学院医药生物技术研究所 4-氧代-2-丁烯酰胺衍生物在制备抑菌剂中的应用
KR101917497B1 (ko) * 2017-02-18 2018-11-09 박병희 신규한 락토바실러스 부크네리 및 이의 용도
TWI607758B (zh) * 2017-03-07 2017-12-11 景岳生物科技股份有限公司 改善乾癬症狀的副乾酪乳桿菌菌株ｇｍｎｌ－６５３及其組合物
AU2018251616B2 (en) * 2017-04-11 2025-04-03 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
EP3764807A4 (en) * 2018-03-14 2021-11-03 Sustainable Community Development, LLC PROBIOTIC AND FOOD ADDITIVE COMPOSITION

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010099024A (ja) * 2008-10-24 2010-05-06 Technical Research & Development Institute Ministry Of Defence 抗炎症効果を有する新規植物性乳酸菌株、該菌株を用いた炎症性腸疾患又は慢性下痢症に対する予防及び治療剤、抑制剤並びに添加剤
JP2016522810A (ja) * 2013-04-23 2016-08-04 テラジェン ホールディングス リミテッドＴｅｒｒａｇｅｎ Ｈｏｌｄｉｎｇｓ Ｌｉｍｉｔｅｄ 抗菌活性を有する細菌株およびそれを含む生物的防除組成物

Also Published As

Publication number Publication date
EP3863656A4 (en) 2022-06-29
EP3863656A1 (en) 2021-08-18
CN114206362A (zh) 2022-03-18
WO2020073088A1 (en) 2020-04-16
SG11202103567RA (en) 2021-05-28
US20210338749A1 (en) 2021-11-04
AU2019356524A1 (en) 2021-05-13
CA3124725A1 (en) 2020-04-16

Similar Documents

Publication Publication Date Title
JP2022504792A (ja) 炎症性疾患及び関連する感染の治療方法
JP7494110B2 (ja) 炎症及び炎症性疾患の治療法
JP6587614B2 (ja) プロバイオティクスとしてのラクトバチルス属の菌株
JP7126004B2 (ja) 組成物及びその使用
AU2019379234B2 (en) Strains, composition and method of use
EP3261723B1 (en) Probiotic lactobacillus plantarum strains for urinary tract infections
JP2023520081A (ja) 炎症性腸疾患に対する併用療法
CN119552773A (zh) 一种卷曲乳杆菌m58d及其组合物
CN119530073B (zh) 一种卷曲乳杆菌x25b及其用途
US20240131089A1 (en) Composition and Use Thereof
US11020440B2 (en) Probiotic for the treatment of psoriasis
CN119530074A (zh) 一种格氏乳杆菌m17c及其组合物
JP2023553956A (ja) 関節の炎症性障害のための併用療法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221011

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221011

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230801

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231025

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240326